Pharmaceutical Industry

Aurora Cannabis slashes Q1 net loss as hunt for savings continues

Canopy Growth sees $42-million net loss in Q1 as cost reduction efforts continue

Cannabis company TerrAscend to list on TSX under TSND ticker in early July

B.C. launching website to book appointments with pharmacists to treat minor ailments

Canopy Growth reports $648-million net loss in fourth-quarter as it parts way with BioSteel staff

NDP attempts to prod Liberals into action on pharmacare by tabling its own bill

Cannabis price ‘race to the bottom’ hurts market’s future, OCS CEO says

Industry blindsided by Ottawa’s plan to track ill effects of natural health products

Federal agency struggled to get pharma companies to engage in drug-price reform, memo shows

Ottawa resumes long-running battle over prescription drug prices

Health minister denies interfering in arm’s-length drug-price agency before committee

Cannabis shop robberies spur push to end restrictions on window displays

Health minister says stiffer regulations could prevent Ozempic-type prescribing

Head of Canada’s drug price regulator resigns same week as colleague steps down

Board member of federal drug-pricing agency resigns over concerns about panel’s independence

Aurora Cannabis records $67.2-million net loss in second quarter

Governments seek buyer as Quebec COVID-19 vaccine manufacturer Medicago set to close